Inhibition of HIV-1 gp41 expression with hammerhead ribozymes
- 21 September 2015
- journal article
- Published by Portland Press Ltd. in Biochemical Journal
- Vol. 471 (1) , 53-66
Abstract
Despite great progress in the treatment of AIDS, the Human Immunodeficiency Virus type I (HIV-1) remains one of the major concerns as a human pathogen. One of the therapeutic strategies against viral infections is the application of catalytic ribonucleic acids (ribozymes) that can significantly reduce expression of a target gene by site-specific hydrolysis of its mRNA. In this paper we report a study on the activity of several variants of hammerhead ribozymes targeting a conserved region within mRNA encoding HIV-1 envelope glycoprotein gp41. Based on the data from in vitro assays and gene silencing in the cultured cells, we propose a new hammerhead ribozyme targeting the gp41-encoding sequence that can be potentially used as a therapeutic agent in AIDS treatment. Moreover, we demonstrate that the hydrolytic activity of the ribozyme in the intracellular environment can not be inferred solely from the results of the in vitro experiments.Keywords
This publication has 70 references indexed in Scilit:
- Spiegelzymes: Sequence Specific Hydrolysis of L-RNA with Mirror Image Hammerhead Ribozymes and DNAzymesPLOS ONE, 2013
- Strategies to Block HIV Transcription: Focus on Small Molecule Tat InhibitorsBiology, 2012
- Knowledge, attitudes and practices of AIDS associated malignancies among people living with HIV in NigeriaInfectious Agents and Cancer, 2012
- Automated 3D structure composition for large RNAsNucleic Acids Research, 2012
- RNA-Based Therapeutics: Current Progress and Future ProspectsChemistry & Biology, 2012
- Phase I/II Clinical Trials Using Gene-Modified Adult Hematopoietic Stem Cells for HIV: Lessons LearntStem Cells International, 2011
- Computational Mutagenesis Studies of Hammerhead Ribozyme CatalysisJournal of the American Chemical Society, 2010
- Phase 2 gene therapy trial of an anti-HIV ribozyme in autologous CD34+ cellsNature Medicine, 2009
- Capturing Hammerhead Ribozyme Structures in Action by Modulating General Base CatalysisPLOS Biology, 2008
- Hammerhead redux: Does the new structure fit the old biochemical data?RNA, 2008